MARSEILLE, France--(BUSINESS WIRE)--May 16, 2012-- Eurobiomed, the health cluster of the South of France, aims to improve the French economy and manages a strong network including more than 200 members (big groups, SMEs, laboratories, university hospitals,.) involved in different fields (pharma, diagnostics, medical devices, ophta, biotech, CRO...). It focuses on 5 STRATEGIC TOPICS: -- Infectious, Tropical and Emerging Diseases -- Rare and Orphan Diseases -- Medical Devices, Biomarkers and Diagnostic -- Immunology and Therapeutic Applications -- Treatment and Care of Aging, Neurological Diseases and Handicap Eurobiomed is recognized as one of the main competitiveness clusters in Europefor healthcare and works to: -- Develop and animate a strong network in life sciences: visits of companies and laboratories, events, working groups,.

-- Support the companies' growth: shared tools and services,.

-- Facilitate access to public fundings for innovative R&D projects: Since 2006, 103 projects accredited by Eurobiomed were successfully funded (R&D budget of more than 280 M?, including at least 90 M? of public fundings and the creation/maintain of 470 positions).

Moreover, Eurobiomed strongly supports its members in the establishment of internationalpartnerships and identification of new market opportunities (bilateral agreements with biotech clusters abroad, establishment of a European Diagnostic Cluster Alliance, organization of international events (EIC 2012, FABS 2012),.

Eurobiomed also applied to the Innovation Express call that fundsa set of innovation support activities to initiate, develop, enhance technological cooperation between European clustersfor the prime benefit of their SME members.

Here below the SMEs members involved in the Innovation Express call: Iris Pharma - -- Latest News - Iris Pharma and RxGen partner to deliver seamless and superior drug & medical devices development services in Ophthalmology.

-- Partnership sought - Developing partnership with pharmaceutical and biotechnology companies for preclinical and clinical development of ocular drugs and devices.

Oribase Pharma - -- Latest News - Oribase Pharma is going to raise 900 000 ? in 2012. The objectives of this fundraising are: Completing the studies of humanization and optimization of antibody (project ORB0003) Optimize the pharmacokinetic property of the major molecules and complete a significant part of the pharmaceutical studies of safety and general toxicity of the medicine ORB0001.

Oxeltis - -- Latest News - Oxeltis is participate to 2012 BIO International Convention. Oxeltis is a successful French service company dedicated to medicinal chemistry and custom synthesis.

-- Partnership sought - Join Oxeltis team at BIO - Booth #1043 or connect to "Bio partnering tool" to request a meeting! Oxeltis is confident about the high value of its team to enhance your future research programs and is looking forward to meeting you soon! Oz Biosciences - -- Latest News - OZ Biosciences announces the launch of a New Range of Magnetofection(TM) Reagents, a unique solution for In Vivo Targeted Nucleic Acids Delivery.

-- Latest News - OZ Biosciences introduces the Viro-MICST(TM) reagent: the next generation of transduction tools.

-- Latest News - OZ Biosciences signed a license and supply agreement with Life Technologies Corporation which allow expanding its transfection solutions portfolio with the launch of Magnetofectamine(TM) Kit, the winning combination for optimal transfection efficiency.

-- Partnership sought - Developing technological partnership, licensing in & out, with innovative companies in molecular delivery systems.

-- Partnership sought - Seeking partnership for commercialization and/or distribution For more information about the 'Innovation Express' program and companies activities, you can directly download the brochure at: CONTACT: Eurobiomed Emilie Royere, Director Camille Arnaud, Project Manager KEYWORD: EUROPE FRANCE INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL SOURCE: Eurobiomed Copyright Business Wire 2012 PUB: 05/16/2012 09:19 AM/DISC: 05/16/2012 09:19 AM